In the News
IBM could replace 7,800 jobs with AI, CEO says
IBM Corp. said it expects to pause hiring for jobs that artificial intelligence could do, indicating that the potentially groundbreaking technology is beginning to disrupt how humans work.
Sponsor
Access to World-Class AI/ML Programs from Top Universities
Developing future-ready skills in artificial intelligence and machine learning are key to unlocking your career growth. Access leading industry experts through dynamic, online courses offered by Emeritus and the world’s leading universities. Explore upcoming AI/ML courses from top global universities and join 250,000+ professionals taking their next step.
In The News
‘Godfather of AI’ Geoffrey Hinton quits Google and warns over dangers of misinformation
The neural network pioneer says dangers of chatbots were ‘quite scary’ and warns they could be exploited by ‘bad actors’
Google, Microsoft CEOs to Discuss AI Issues at White House as Concerns Rise Over Risks
Concerns about fast-growing AI technology include privacy violations, bias and worries it could proliferate scams and misinformation.
Applied use cases
How AI is accelerating innovation in healthcare
Healthcare — one of the largest sectors of the U.S. economy — is among the many industries with significant opportunities for the use of artificial intelligence (AI) and machine learning (ML), says Salveen Richter, lead analyst for the U.S. biotechnology sector at Goldman Sachs Research.
Could AI save the Amazon rainforest?
Conservationists in the Brazilian Amazon are using a new tool to predict the next sites of deforestation – and it may prove a gamechanger in the war on logging
We showed people an AI political ad. Can they tell it's fake?
A transformative and largely untested technology looks set to revolutionize political campaigning: artificial intelligence. AI blurs the lines between fact and fiction and is raising concerns ahead of the 2024 presidential election. Donie O'Sullivan reports.
Ethics
Geoffrey Hinton, a pioneer in artificial intelligence, resigns from Google over ethical fears
Geoffrey Hinton, a pioneer in artificial intelligence (AI) and a longtime leader of Google’s AI research division, has resigned from his position at the tech giant, citing growing concerns about the ethical implications of the technology he helped create, the New York Times reported on Monday.
UNESCO launches Women4Ethical AI expert platform to advance gender equality
UNESCO launched Women4Ethical AI, a new collaborative platform to support governments and companies’ efforts to ensure that women are represented equally in both the design and deployment of AI.
Towards actionable governance on trustworthy AI
In 2022, the global AI market was estimated to be worth $120 billion; forecasts expect that to reach $1.6 trillion by 2030.
Robotics
40+ Years of Vision Guided Robotics
Since the beginning of modern industrial robots in the early 1980s, robots have been guided by machine vision.
Kodiak Robotics Introduces First-Ever Autonomous Electric Class 8 Truck
Kodiak is upfitting a Peterbilt Model 579EV electric truck with the Kodiak Driver, the company's self-driving technology. The truck will be incorporated into Kodiak's fleet in 2024.
Surgical robotics training facility inaugurated at AIIMS, Delhi
The AIIMS Delhi has inaugurated a state-of-the-art surgical robotics training facility at the SET -- skill, e-learning and telemedicine facility -- of the institute.
Research
New Tool Helps AI and Humans Learn To Code Better
Stanford researchers developed a new framework called Parsel that solves complex coding tasks the way humans do — breaking down big tasks into smaller ones.
Researchers develop a deep learning model to classify cancer cells by type
Cancer cells that initiate metastasis, or the spread of the disease from its primary location, are different from cancer cells that stay in the original tumor.
Uncovering expression signatures of synergistic drug responses via ensembles of explainable machine-learning models
Machine learning may aid the choice of optimal combinations of anticancer drugs by explaining the molecular basis of their synergy.